Form 4: Vor Biopharma Insider Reports Stock Transaction
Insider Transaction (Form 4)
Ra Capital Management, L.P. and 3 others reported changes in beneficial ownership of Vor Biopharma Inc. common stock on October 2, 2026.
Summary
- Option exercise/conversion: acquired 500 Common Stock at $12.80 ($6,400) on October 2, 2026; holds 500 after (Indirect).
- Option exercise/conversion: disposed of 500 Stock Option (Right to Buy) on October 2, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ra Capital Management, L.P. — 10% owner
RA Capital Healthcare Fund LP — 10% owner
Peter Kolchinsky — 10% owner
Rajeev M. Shah — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Option exercise/conversion | Common Stock | 500 | $13 | $6.4K | 500 |
| 2026-10-02 | Option exercise/conversion | Stock Option (Right to Buy) | 500 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Option exercise/conversion (500 shares) |
| 2026-10-02 | Option exercise/conversion (500 shares) |
Keywords
insider transaction, Form 4, VOR, Vor Biopharma Inc., neutral, Ra Capital Management, L.P., RA Capital Healthcare Fund LP, Peter Kolchinsky, Rajeev M. Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.